Guggenheim Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$765K Sell
56,481
-30,341
-35% -$363K ﹤0.01% 1119
2026
Q1
$520K Sell
86,822
-64,880
-43% -$488K ﹤0.01% 1196
2025
Q4
$1.09M Buy
151,702
+40,625
+37% +$321K 0.01% 912
2025
Q3
$1.19M Sell
111,077
-29,486
-21% -$289K 0.01% 864
2025
Q2
$1.36M Buy
140,563
+17,762
+14% +$183K 0.01% 784
2025
Q1
$1.83M Buy
122,801
+27,297
+29% +$420K 0.02% 667
2024
Q4
$1.42M Buy
95,504
+8,935
+10% +$146K 0.01% 768
2024
Q3
$1.66M Sell
86,569
-7,780
-8% -$161K 0.01% 881
2024
Q2
$1.95M Buy
94,349
+14,905
+19% +$296K 0.01% 823
2024
Q1
$1.49M Buy
79,444
+6,215
+8% +$107K 0.01% 1016
2023
Q4
$1.06M Sell
73,229
-20,044
-21% -$273K 0.01% 1137
2023
Q3
$1.62M Buy
93,273
+3,345
+4% +$69.8K 0.01% 887
2023
Q2
$1.87M Sell
89,928
-53,938
-37% -$1.17M 0.01% 885
2023
Q1
$3.38M Buy
143,866
+19,389
+16% +$521K 0.03% 658
2022
Q4
$3.48M Buy
124,477
+38,505
+45% +$985K 0.03% 652
2022
Q3
$2.01M Buy
85,972
+10,767
+14% +$325K 0.02% 838
2022
Q2
$2.54M Sell
75,205
-35,706
-32% -$1.25M 0.02% 801
2022
Q1
$3.87M Buy
110,911
+7,254
+7% +$248K 0.02% 756
2021
Q4
$3.16M Buy
103,657
+19,872
+24% +$647K 0.02% 866
2021
Q3
$2.75M Sell
83,785
-14,855
-15% -$475K 0.02% 891
2021
Q2
$2.98M Buy
+98,640
New +$3.25M 0.02% 890

Other funds holding OGN

Guggenheim Capital's OGN Position: Q2 2026 in Review

Guggenheim Capital reduced its Organon & Co (OGN) stake by 35% in Q2 2026, selling an estimated $363K and leaving 56,481 shares worth $765K. The position accounts for ﹤0.01% of the portfolio, ranked #1119.

Guggenheim Capital first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.87M in Q1 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Guggenheim Capital held 56,481 shares of Organon & Co worth $765K as of Q2 2026.
  • Guggenheim Capital sold 30,341 Organon & Co shares in Q2 2026, an estimated $363K.
  • Organon & Co made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1119 holding.
  • Guggenheim Capital first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Guggenheim Capital's Organon & Co position peaked at $3.87M in Q1 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.